Narayana Hrudayalaya Limited
NH
Rank in Stocks
#4149
Narayana Hrudayalaya Limited, established in 2000 and headquartered in... Narayana Hrudayalaya Limited, established in 2000 and headquartered in Bengaluru, India, operates as a prominent provider of medical and healthcare services. The company oversees and manages a diverse range of healthcare facilities, encompassing hospitals, clinics, health centers, and nursing homes. It delivers specialized care across a comprehensive spectrum of medical disciplines, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicine, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, Narayana Hrudayalaya maintained an extensive network that included 19 owned or operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers throughout India, complemented by an international presence with one hospital in the Cayman Islands. Additionally, the company extends its expertise through healthcare consultancy services, which involve the licensing of its ERP solutions.
Share Price
$19.12
Last synced: 2026-10-19
Market Cap
$3.88B
Change (1 day)
1.30%
Change (1 year)
-4.61%
Country
IN
Trade Narayana Hrudayalaya Limited (NH)
Category
Healthcare
P/E ratio for Narayana Hrudayalaya Limited (NH)
P/E ratio as of October 2026 TTM: 42.94
According to Narayana Hrudayalaya Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.94. At the end of 2024 the company had a P/E ratio of 33.51.
P/E ratio history for Narayana Hrudayalaya Limited from 2011 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 42.94 | -0.48% |
| 2025 | 43.15 | 28.75% |
| 2024 | 33.51 | 29.24% |
| 2023 | 25.93 | -41.39% |
| 2022 | 44.24 | -107.68% |
| 2021 | -575.74 | -1,463.32% |
| 2020 | 42.23 | -43.10% |
| 2019 | 74.22 | -33.04% |
| 2018 | 110.86 | 44.96% |
| 2017 | 76.47 | -74.51% |
| 2016 | 300.01 | -150.65% |
| 2015 | -592.28 | -372.73% |
| 2014 | 217.17 | -21.80% |
| 2013 | 277.70 | 3.86% |
| 2012 | 267.37 | -47.03% |
| 2011 | 504.80 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 15.70 | -63.43% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -75.79% |
US
|
|
| 32.07 | -25.32% |
SA
|
|
| 20.00 | -53.42% |
BR
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.